Newsroom
Sorted by: Latest
-
KlariVis Names Marcos Souza Chief Data & Analytics Officer, Elevates Guy DeCorte to Chief AI Officer
ROANOKE, Va.--(BUSINESS WIRE)--KlariVis expands its C-Suite with two roles to accelerate its data and AI roadmap, naming a Chief Data & Analytics Officer and Chief AI Officer....
-
Mobileye Announces Timing of its Second Quarter 2026 Results
JERUSALEM--(BUSINESS WIRE)--Mobileye Global Inc. (Nasdaq: MBLY) (“Mobileye”) today announced that it will release its financial results for the second quarter 2026 on Thursday, July 23rd, 2026, before market open. Mobileye will host a conference call at 8:00am ET (3:00pm IT) to review its results and provide a general business update. The call will be hosted by Professor Amnon Shashua, CEO, Moran Shemesh Rojansky, CFO, Nimrod Nehushtan, EVP – Business Development and Strategy, and Dan Galves, C...
-
DraftKings Set to Launch Online Sportsbook and Casino in Alberta on July 13
BOSTON--(BUSINESS WIRE)--DraftKings Inc. (Nasdaq: DKNG) today announced plans to launch its top-rated online sportsbook and casino, along with its Golden Nugget Online Gaming brand, in Alberta on July 13. Alberta will become the second Canadian province and the 34th jurisdiction across North America where DraftKings Sportsbook is available. With the launch, DraftKings Casino will be available in five U.S. states and Golden Nugget Online Gaming casino in four U.S. states, with both brands availa...
-
Snap-on Incorporated to Webcast 2026 Second Quarter and Six-Month Results Conference Call
KENOSHA, Wis.--(BUSINESS WIRE)--Snap-on will release 2026 second quarter and six-month results on Thursday, July 23, 2026 with a call discussing the results to follow at 10:00 am ET....
-
Videotron Selects Vecima’s Entra® vCMTS to Advance Next-Generation DOCSIS Networks in Canada
VICTORIA, British Columbia--(BUSINESS WIRE)--Vecima announces Videotron has selected the Entra vCMTS, EN9000 GAP Node, and ERM3 RPD to support the evolution of its next-gen DOCSIS network....
-
Addionics Launches Autonomous Architecture™, the Battery Design for the Always-On AI World
TEL AVIV, Israel--(BUSINESS WIRE)--Addionics, a pioneer in advanced battery architecture, today unveiled Addionics Autonomous Architecture™, a breakthrough smart battery architecture built for the always-on AI economy. As intelligent machines increasingly operate 24/7, the technology enables batteries to deliver higher performance, longer life, and greater efficiency under continuous, high-demand operations. It is designed for autonomous vehicles, robotics, satellites, drones, and next-generati...
-
Elucid Announces First Patient Enrollment in AI-PREDICT, a Landmark International Study to Define Lesion-Level Cardiovascular Risk
BOSTON--(BUSINESS WIRE)--Elucid, an innovator in AI-powered coronary CT angiography (CCTA) analysis, today announced first patient enrollment in AI-PREDICT, a retrospective, international, multicenter study designed to establish a new lesion-centric paradigm for cardiovascular risk stratification. Enrollment is underway at three of more than 20 planned sites across the U.S., Europe, and Asia: Emory University, the Medical University of South Carolina, and Centro Cardiologico Monzino, Milan, led...
-
NeoGenomics Launches FDA-Approved PTEN IHC Companion Diagnostic for Prostate Cancer
FORT MYERS, Fla.--(BUSINESS WIRE)--NeoGenomics launched PTEN IHC CDx, the first IHC companion diagnostic test approved by the U.S. FDA for patients with prostate adenocarcinoma....
-
AccurKardia and Wellysis Sign Multi-Year Agreement to Provide Wellysis’ Turnkey Cardiac Monitoring Offering in the U.S. Market
NEW YORK & SEOUL--(BUSINESS WIRE)--AccurKardia, Inc., an ECG-led diagnostics software company, and Wellysis, a digital healthcare company and developer of the S-Patch wearable ECG monitor, today announced a multi-year agreement under which AccurKardia’s AccurECG 2.0 will power the analytics behind Wellysis’ turnkey cardiac monitoring offering in the U.S. The agreement, which was signed last week in Seoul, is the latest between the two companies.Under the agreement, Wellysis’ S-Patch wearable dev...
-
Altasciences et Evidence Matters font progresser le développement de médicaments basé sur l'IA grâce à une avancée majeure en matière d'automatisation des essais précliniques
LAVAL, Québec--(BUSINESS WIRE)--Altasciences, une organisation entièrement intégrée spécialisée dans le développement de médicaments en phase précoce, et Evidence Matters, pionnier dans le domaine de la science des données issues des essais cliniques, ont le plaisir d’annoncer la réussite d’une démonstration de concept (POC) de RegulatoryFlow (« RegFlow »), suite à l’annonce de leur collaboration stratégique en août 2025. Cette validation de principe a démontré que les gains d’efficacité généré...